UYEN NGOC MUI: Open Payments
NPI 1033572136 · KATY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,207 in 168 payments from 15 companies in 2025. Trend: 2023 $3,192 · 2024 $1,104 · 2025 $3,207
Food & beverage: $2,945Education: $262
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 41 | $577 |
| Janssen Biotech, Inc. | 26 | $530 |
| Novartis Pharmaceuticals Corporation | 12 | $280 |
| Arcutis Biotherapeutics, Inc. | 14 | $247 |
| Incyte Corporation | 13 | $238 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $212 |
| Lilly USA, LLC | 13 | $212 |
| Regeneron Healthcare Solutions, Inc. | 9 | $192 |
| GENZYME CORPORATION | 7 | $188 |
| Organon LLC | 8 | $185 |
Products named: TREMFYA, DUPIXENT, RINVOQ, SKYRIZI, COSENTYX, Zoryve, OPZELURA, CIBINQO.
Industry payments across TX — which companies pay providers there.
